In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 1644 for your search:
Drug:  cyclophosphamide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV, Phase III
Type: Treatment
Status: Unknown
Age: 21 and under
Sponsor: Other
Protocol IDs: GPOH-NB2004, EU-20661, NCT00410631

2.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 15 to 70
Sponsor: Other
Protocol IDs: OLSG-0401, NCT00162955

3.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004

4.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 45
Sponsor: Other
Protocol IDs: 0501-37, NCT00352872

5.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2006-003750-23, LINFOTARGAM, NCT00466258

6.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: Other
Protocol IDs: LAL-RI/96, NCT00494897

7.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: LAL-Ph-2000, NCT00526305

8.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017

9.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: TaCyDexVMP7, NCT00652041

10.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-00055-18, NCT00415103

11.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 50 and under
Sponsor: Other
Protocol IDs: CDR0000066400, MSGCC-9739, NCI-V98-1433, NCT00003398

12.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML25137, NCT01283386

13.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: GEICAM/2009-02, 2010-022689-29, NCT01298193

14.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: RJ-2010-56, NCT01358253

15.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CHOP-Z, NCT01418430

16.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 16 to 65
Sponsor: Other
Protocol IDs: HDE-ALL-2011, NCT01457040

17.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor: NCI
Protocol IDs: EST-PE-179

18.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-86-C-92A, NCI-NMOB-855, NCI-T86-0137N, T86-0137

19.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1586

20.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 16 to physiologic 70
Sponsor: NCI
Protocol IDs: CLB-8642, CALGB-8642

21.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1277R

22.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: MRH-860408, NCI-V86-0099

23.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: SJCRH-RMS-V, NCI-T86-0152D, T86-0152

24.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: POG-8741/42, POG-8741, POG-8742

25.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 75
Sponsor: NCI
Protocol IDs: EST-1878
1     
New Search